ACTOS

Brand name authorized in: Austria Australia Spain Hong Kong Ireland Italy Lithuania Netherlands Poland Singapore Tunisia United Kingdom United States

Active ingredients

The drug ACTOS contains one active pharmaceutical ingredient (API):

1 Pioglitazone
UNII JQT35NPK6C - PIOGLITAZONE HYDROCHLORIDE

Pioglitazone effects may be mediated by a reduction of insulin resistance. Pioglitazone appears to act via activation of specific nuclear receptors (peroxisome proliferator activated receptor gamma) leading to increased insulin sensitivity of liver, fat and skeletal muscle cells in animals. Treatment with pioglitazone has been shown to reduce hepatic glucose output and to increase peripheral glucose disposal in the case of insulin resistance.

Read about Pioglitazone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
A10BG03
Pioglitazone
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BG Thiazolidinediones
Discover more medicines within A10BG03

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
ACTOS Tablet
Structured Product Labeling (SPL/PLR)
US

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 8694N, 8695P, 8696Q
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 00150001, 00150004, 00150004IP, 00150009, 00150010, 00150010IP
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 140403, 140405, 161338, 175725, 175728, 178953, 180500, 198640, 20095, 20096, 374281, 374283, 374285, 51997
HK
Department of Health Drug Office
Identifier(s): 47882, 47884
IE
Health Products Regulatory Authority
Identifier(s): 10330, 10378, 10506, 10568, 10594, 10609, 10661, 10756, 10761, 10797, 10798, 15530, 15590
IT
Agenzia Italiana del Farmaco
Identifier(s): 034946018, 034946044, 034946121
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1004071, 1004363, 1004508, 1026399, 1026400, 1026401, 1026402, 1026403, 1026404, 1026405, 1026406, 1026407, 1026408, 1026409, 1026410, 1026411, 1026412, 1026413, 1026414, 1026415, 1026416, 1026417, 1026418, 1026419, 1063617, 1063618, 1063619, 1063620, 1063621, 1063622
NL
Z-Index G-Standaard, PRK
Identifier(s): 84247, 84255
PL
Rejestru Produktów Leczniczych
Identifier(s): 100308456, 100308462, 100308479
SG
Health Sciences Authority
Identifier(s): 12441P, 12442P
TN
Direction de la Pharmacie et du Médicament
Identifier(s): 5063311, 5063312
US
FDA, National Drug Code
Identifier(s): 64764-151, 64764-301, 64764-451